Funding source for this study was Medtronic, Inc.
Elevated T-Wave Alternans Predicts Nonsustained Ventricular Tachycardia in Association with Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (STEMI) Patients
Article first published online: 27 FEB 2013
© 2013 Wiley Periodicals, Inc.
Journal of Cardiovascular Electrophysiology
Volume 24, Issue 6, pages 658–663, June 2013
How to Cite
VERRIER, R. L., NEARING, B. D., GHANEM, R. N., OLSON, R. E., GARBERICH, R. F., KATSIYIANNIS, W. T., GORNICK, C. C., TANG, C. Y. and HENRY, T. D. (2013), Elevated T-Wave Alternans Predicts Nonsustained Ventricular Tachycardia in Association with Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (STEMI) Patients. Journal of Cardiovascular Electrophysiology, 24: 658–663. doi: 10.1111/jce.12102
R.N. Ghanem is an employee of Medtronic, Inc. B.D. Nearing and R.L. Verrier are inventors of the Modified Moving Average method for analysis of T-wave alternans and receive royalty or licensing income from Georgetown University and Beth Israel Deaconess Medical Center for intellectual property licensed to GE Healthcare and to Medtronic. Other authors: No disclosures.
- Issue published online: 4 JUN 2013
- Article first published online: 27 FEB 2013
- Accepted manuscript online: 22 JAN 2013 04:22AM EST
- Manuscript Accepted: 21 DEC 2012
- Manuscript Revised: 18 DEC 2012
- Manuscript Received: 24 JUL 2012
- Medtronic, Inc.
- myocardial infarction;
- ventricular tachycardia;
- T-wave alternans
TWA and Arrhythmias in STEMI After PCI
Successful reperfusion with primary percutaneous coronary intervention (PCI) can paradoxically elicit temporary vulnerability to ventricular arrhythmia. We examined whether T-wave alternans (TWA) level is correlated with nonsustained ventricular tachycardia (NSVT) incidence in association with PCI in patients with acute ST-segment elevation myocardial infarction (STEMI).
Methods and Results
We analyzed continuous 24-hour ambulatory electrocardiograms in 48 STEMI patients during and after successful primary PCI, achieving Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow. TWA was measured using modified moving average method. Maximum TWA was elevated in patients with (N = 22) compared to without (N = 26) NSVT (75.1 ± 6.3 vs 49.9 ± 3.6 μV, P < 0.005) during the 22-hour monitoring period. TWA ≥ 60μV predicted NSVT with sensitivity of 77%; specificity, 73%; positive predictive value, 71%; and negative predictive value, 79%. Area under receiver operator characteristic curve (AUC) was 0.87 for maximum TWA in predicting NSVT. By comparison, ST-segment levels did not differ in patients with versus without NSVT and were not predictive (AUC = 0.52). TWA was elevated prior to PCI and remained elevated at 30 minutes after balloon inflation despite restoration of TIMI grade 3 flow in all patients, declining by 22 hours (P < 0.05). Maximum ST-segment levels decreased from before PCI to 30 minutes after balloon inflation. TWA is regionally specific, with higher values prior to PCI in precordial lead V5 than in V1 for left coronary lesions.
TWA may be useful in identifying individuals at heightened risk for arrhythmia in association with primary PCI and can potentially signal time-dependent changes in arrhythmia vulnerability.